Literature DB >> 12950259

Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3).

Nikolaos Biris1, Morfis Abatzis, John V Mitsios, Maria Sakarellos-Daitsiotis, Constantinos Sakarellos, Demokritos Tsoukatos, Alexandros D Tselepis, Lambros Michalis, Dimitrios Sideris, Georgia Konidou, Ketty Soteriadou, Vassilios Tsikaris.   

Abstract

alpha(IIb)beta(3), a member of the integrin family of adhesive protein receptors, is the most abundant glycoprotein on platelet plasma-membranes and binds to adhesive proteins via the recognition of short amino acid sequences, for example the ubiquitous RGD motif. However, elucidation of the ligand-binding domains of the receptor remains controversial, mainly owing to the fact that integrins are conformationally labile during purification and storage. In this study, a detailed mapping of the extracellular region of the alpha(IIb) subunit is presented, using overlapping 20-peptides, in order to identify the binding sites of alpha(IIb) potentially involved in the platelet-aggregation event. Regions alpha(IIb) 313-332, alpha(IIb) 265-284 and alpha(IIb) 57-64 of alpha(IIb)beta(3) were identified as putative fibrinogen-binding domains because the corresponding peptides inhibited platelet aggregation and antagonized fibrinogen association, possibly by interacting with this ligand. The latter is further supported by the finding that the above peptides did not interfere with the binding of PAC-1 to the activated form of alpha(IIb)beta(3). Furthermore, alpha(IIb) 313-332 was found to bind to fibrinogen in a solid-phase binding assay. It should be emphasized that all the experiments in this study were carried out on activated platelets and consequently on the activated form of this integrin receptor. We hypothesize that RAD and RAE adhesive motifs, encompassed in alpha(IIb) 313-332, 265-284 and 57-64, are capable of recognizing complementary domains of fibrinogen, thus inhibiting the binding of this ligand to platelets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950259     DOI: 10.1046/j.1432-1033.2003.03762.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Exploration of the antiplatelet activity profile of betulinic acid on human platelets.

Authors:  Andreas G Tzakos; Vassiliki G Kontogianni; Maria Tsoumani; Eleni Kyriakou; John Hwa; Francisco A Rodrigues; Alexandros D Tselepis
Journal:  J Agric Food Chem       Date:  2012-07-03       Impact factor: 5.279

2.  Characterizing the modification of surface proteins with poly(ethylene glycol) to interrupt platelet adhesion.

Authors:  Haiyan Xu; Joel L Kaar; Alan J Russell; William R Wagner
Journal:  Biomaterials       Date:  2006-02-02       Impact factor: 12.479

Review 3.  In vivo gene delivery mediated by non-viral vectors for cancer therapy.

Authors:  Reza Mohammadinejad; Ali Dehshahri; Vijay Sagar Madamsetty; Masoumeh Zahmatkeshan; Shima Tavakol; Pooyan Makvandi; Danial Khorsandi; Abbas Pardakhty; Milad Ashrafizadeh; Elham Ghasemipour Afshar; Ali Zarrabi
Journal:  J Control Release       Date:  2020-07-04       Impact factor: 9.776

4.  Identification of the pollen self-incompatibility determinant in Papaver rhoeas.

Authors:  Michael J Wheeler; Barend H J de Graaf; Natalie Hadjiosif; Ruth M Perry; Natalie S Poulter; Kim Osman; Sabina Vatovec; Andrea Harper; F Christopher H Franklin; Vernonica E Franklin-Tong
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

5.  Inhibition of αIIbβ3 Ligand Binding by an αIIb Peptide that Clasps the Hybrid Domain to the βI Domain of β3.

Authors:  Wen Hwa Lee; Elisabeth Schaffner-Reckinger; Demokritos C Tsoukatos; Kelly Aylward; Vassilios Moussis; Vassilios Tsikaris; Paraskevi Trypou; Marion Egot; Dominique Baruch; Nelly Kieffer; Christilla Bachelot-Loza
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

6.  Diabetes and Hyperglycemia Affect Platelet GPIIIa Expression. Effects on Adhesion Potential of Blood Platelets from Diabetic Patients under In Vitro Flow Conditions.

Authors:  Tomasz Przygodzki; Boguslawa Luzak; Hassan Kassassir; Ewelina Mnich; Magdalena Boncler; Karolina Siewiera; Marcin Kosmalski; Jacek Szymanski; Cezary Watala
Journal:  Int J Mol Sci       Date:  2020-05-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.